At one point in Kelly's care one of the Hospice nurses ordered Reglan for Kelly without asking me. The rule in my house was nothing went into Kelly's mouth until I investigated the drug. When I read about the scary potential side effects from Reglan [like tardive dyskinesia and Neuroleptic malignant syndrome], I wouldn't allow hospice to give it to her!!!
Everytime I hear someone is on Reglan, I send this RED FLAG message:
Families of Huntington's Disease patients should exercise caution when this medication is prescribed, especially for those on feeding tubes. Discuss any concerns about a person with Huntington's taking this medication with the physician. If the decision is made to put your loved on Reglan, special attention should be made to look for the serious side affects and report them to the doctor as soon as possible.
Reglan
Generic name: Metoclopramide hydrochloride
Reglan increases the contractions of the stomach and small intestine, helping the passage of food. It is given to treat the symptoms of diabetic gastroparesis, a condition in which the stomach does not contract. These symptoms include vomiting, nausea, heartburn, feeling of indigestion, persistent fullness after meals, and appetite loss.
Symptoms of Gastroesophageal Reflux
The usual dose is 10 milligrams to 15 milligrams of Reglan, up to 4 times a day, 30 minutes before each meal and at bedtime, depending upon the symptoms being treated and the effectiveness of the dose. Treatment usually lasts no longer than [KEY WORD}12 weeks. Reglan is not recommended for patients under 18 years of age.
In other words, Reglan is not a long-term use drug or one for children!
Wikipedia [
en.wikipedia.org]
Metoclopramide is commonly used to treat nausea and vomiting (emesis) associated with conditions including: emetogenic drugs, uraemia, radiation sickness, malignancy, labor, and infection. It is also used by itself or in combination with paracetamol (acetaminophen) for the relief of migraine. It is considered INeffective in postoperative nausea and vomiting (PONV) at standard doses, and INeffective for motion sickness. In nausea and vomiting associated with cancer chemotherapy, it has been SUPERCEDED by the more effective 5-HT3 antagonists (e.g. ondansetron).
Common adverse drug reactions (ADRs) associated with metoclopramide therapy include: restlessness, drowsiness, dizziness, and/or headache. Infrequent ADRs include: extrapyramidal effects (EPSE) such as oculogyric crisis (and other acute dystonic reactions), hypertension, hypotension, hyperprolactinaemia leading to galactorrhoea, diarrhoea, constipation, and/or depression. Rare but serious ADRs associated with metoclopramide therapy include: agranulocytosis, supraventricular tachycardia, hyperaldosteronism, neuroleptic malignant syndrome and/or tardive dyskinesia.
The risk of EPSEs are increased in young adults (<20 years) and children. Such dystonic reactions are usually treated with benztropine or procyclidine. The risk of tardive dyskinesia and EPSE is increased with high dose therapy and with prolonged use. Tardive dyskinesias may be persistent and irreversible in some patients.
ENOUGH TO SCARE YOU YET?
Metoclopramide is classified as an anti-emetic (anti-vomiting) drug. It blocks the chemical dopamine in parts of the brain to provide a central anti-vomiting effect. It also stimulates the contraction of the stomach and of the upper portion of the small intestine. These actions occur without stimulating secretions of digestive enzymes. Metoclopramide also increases the pressure at the lower esophageal sphincter. This can reduce or prevent stomach acid from entering the esophagus (a condition called gastro-esophageal reflux). The drug is also used to stimulate stomach and intestinal motility when these motions are abnormally reduced.
Sounds good huh?
FDA on Reglan: [
www.drugs.com]
In pediatric patients, the pharmacodynamics of metoclopramide following oral and intravenous administration are highly variable and a concentration-effect relationship has not been established. Safety and effectiveness in pediatric patients have not been established except as stated to facilitate small bowel intubation. The safety profile of metoclopramide in adults cannot be extrapolated to pediatric patients. [KEY WORDS} Dystonias and other extrapyramidal reactions associated with metoclopramide are more common in the pediatric population than in adults.
Metoclopramide should not be used in epileptics or patients receiving other drugs which are likely to cause extrapyramidal reactions, since the frequency and severity of seizures or extrapyramidal reactions may be increased.
Gastrointestinal: Nausea and bowel disturbances, primarily diarrhea. [HMMM, it's supposed to help nausea but causes it?]